Funded Tech Companies
Primmune Therapeutics
Researching who invested in Primmune Therapeutics? Biobrit, CAM Capital and Polaris Partners joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Primmune Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
3210 Merryfield Row
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Primmune Therapeutics is harnessing the power of the innate immune system to develop small molecule, orally administered toll-like receptor 7 (TLR7) agonists as immunotherapies for the treatment of cancer and viral diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/28/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Charles McDermott
Vice President
Stephen Webber
VP - Bus. Development
Paulo Rangel
VP - R & D
James Appleman
Company Investors
- Biobrit
- CAM Capital (Scott Morenstein)
- Polaris Partners (Amir Nashat)
- BioRock Ventures
- Samsara BioCapital
- Oberland Capital (Andrew Rubinstein)
- Private Investors (Charlie McDermott)
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs